Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 21518751)

1.

Applying health economics for policy decision making: do devices differ from drugs?

Sorenson C, Tarricone R, Siebert M, Drummond M.

Europace. 2011 May;13 Suppl 2:ii54-8. doi: 10.1093/europace/eur089.

2.

Cardiac resynchronization therapy: a cost or an investment?

Boriani G, Mantovani LG, Biffi M, Schalij MJ, Martignani C, Leclercq C, Bax JJ, Auricchio A.

Europace. 2011 May;13 Suppl 2:ii32-8. doi: 10.1093/europace/eur079.

3.

What are the costs of atrial fibrillation?

Blomstrom Lundqvist C, Lip GY, Kirchhof P.

Europace. 2011 May;13 Suppl 2:ii9-12. doi: 10.1093/europace/eur087.

4.

Remote monitoring: a cost or an investment?

Burri H, Heidbüchel H, Jung W, Brugada P.

Europace. 2011 May;13 Suppl 2:ii44-8. doi: 10.1093/europace/eur082.

5.

Cardioverter-defibrillators: a cost or an investment?

Leyva F, Fernandez Lozano I, Morgan J.

Europace. 2011 May;13 Suppl 2:ii25-31. doi: 10.1093/europace/eur085.

6.

A comparative economic analysis of pegylated liposomal doxorubicin versus topotecan in ovarian cancer in the USA and the UK.

Smith DH, Adams JR, Johnston SR, Gordon A, Drummond MF, Bennett CL.

Ann Oncol. 2002 Oct;13(10):1590-7.

7.

Economic evaluation and mental health: sparse past. fertile future?

Knapp M.

J Ment Health Policy Econ. 1999 Dec 1;2(4):163-167.

PMID:
11967427
8.

Atrial fibrillation ablation: a cost or an investment?

Kautzner J, Bulkova V, Hindricks G, Maniadakis N, Della Bella P, Jaïs P, Kuck KH.

Europace. 2011 May;13 Suppl 2:ii39-43. doi: 10.1093/europace/eur084.

9.

A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.

10.

Device therapy and hospital reimbursement practices across European countries: a heterogeneous scenario.

Boriani G, Burri H, Mantovani LG, Maniadakis N, Leyva F, Kautzner J, Lubinski A, Braunschweig F, Jung W, Lozano IF, Fattore G.

Europace. 2011 May;13 Suppl 2:ii59-65. doi: 10.1093/europace/eur080.

11.

The influence of economic evaluation studies on decision making. A European survey. The EUROMET group.

Hoffmann C, Graf von der Schulenburg JM.

Health Policy. 2000 Jul;52(3):179-92.

PMID:
10862993
12.

Systematic reviews of economic evaluations: utility or futility?

Anderson R.

Health Econ. 2010 Mar;19(3):350-64. doi: 10.1002/hec.1486.

PMID:
19378354
13.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

14.

Health economics and the European Heart Rhythm Association.

Vardas P, Boriani G.

Europace. 2011 May;13 Suppl 2:ii1-2. doi: 10.1093/europace/eur090.

15.

What are the costs of heart failure?

Braunschweig F, Cowie MR, Auricchio A.

Europace. 2011 May;13 Suppl 2:ii13-7. doi: 10.1093/europace/eur081.

16.

Prospective trials of implantable cardioverter defibrillators versus drugs: are they addressing the right question?

Josephson M, Nisam S.

Am J Cardiol. 1996 Apr 15;77(10):859-63. Review. No abstract available.

PMID:
8623740
18.

Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.

Spottke EA, Volkmann J, Lorenz D, Krack P, Smala AM, Sturm V, Gerstner A, Berger K, Hellwig D, Deuschl G, Freund HJ, Oertel WH, Dodel RC.

J Neurol. 2002 Jun;249(6):759-66.

PMID:
12111311
19.

Expensive care - a rationale for economic evaluations in intensive care.

Higgins AM, Pettila V, Bellomo R, Harris AH, Nichol AD, Morrison SS.

Crit Care Resusc. 2010 Mar;12(1):62-6. Review.

PMID:
20196716
20.

Economic evaluation and health care decision-making.

Rutten F.

Health Policy. 1996 Jun;36(3):215-29.

PMID:
10158267
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk